DEA Places Veterinary Anesthetic into Schedule IV
The Drug Enforcement Administration placed the drug alfaxalone into Schedule IV of the Controlled Substances Act. The substance was approved by the Food and Drug Administration as an anesthetic for cats and dogs in 2012. Effective March 31, alfaxalone will be subject to new registration, labeling, recordkeeping, and import and export requirements.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
(Federal Register 02/27/14)